Issue Price
₹123
Per Share
GMP
NIL
Grey Market
Est. Listing
₹123
Expected Price
Min. Application
₹246,000
2 lots × 1000 shares
Asston Pharmaceuticals Ltd. is proposing an Initial Public Offering (IPO) on the BSE SME platform under the SME category.
Subscription opens 09 Jul 2025, closes 11 Jul 2025. Listing expected 19 Jul 2025. Apply via ASBA or UPI.
Asston Pharmaceuticals Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹123,000 |
| Retail (Max) | 13 | 13,000 | ₹1,599,000 |
| sNII (Min) | 14 | 14,000 | ₹1,722,000 |
| bNII (Min) | 68 | 68,000 | ₹8,364,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |